MEF2C Antikörper (Thr300)

Produktnummer ABIN545865

Produktdetails anti-MEF2C Antikörper

Target: MEF2C (Myocyte Enhancer Factor 2C (MEF2C))

Bindungsspezifität: Thr300

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser MEF2C Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Verwendungszweck: Rabbit polyclonal antibody raised against synthetic peptide of MEF2C.

Kreuzreaktivität: Human

Immunogen: A synthetic peptide (conjugated with KLH) corresponding to residues surrounding T300 of human MEF2C.

Anwendungsinformationen

Applikationshinweise: ELISA (1:1000)
Western Blot (1:50-100)
Immunohistochemistry (1:10-50)
The optimal working dilution should be determined by the end user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In PBS (0.09 % sodium azide)

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Referenzen für anti-MEF2C Antikörper (ABIN545865)

Konig, Hinard, Arnaudeau, Holzer, Potter, Bader, Bernheim: "Membrane hyperpolarization triggers myogenin and myocyte enhancer factor-2 expression during human myoblast differentiation." in: The Journal of biological chemistry, Vol. 279, Issue 27, pp. 28187-96, (2004) (PubMed).

Maeda, Chapman, Stewart: "Mammalian vestigial-like 2, a cofactor of TEF-1 and MEF2 transcription factors that promotes skeletal muscle differentiation." in: The Journal of biological chemistry, Vol. 277, Issue 50, pp. 48889-98, (2002) (PubMed).

Maeda, Gupta, Stewart: "TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters." in: Biochemical and biophysical research communications, Vol. 294, Issue 4, pp. 791-7, (2002) (PubMed).

Details zu MEF2C

Target: MEF2C (Myocyte Enhancer Factor 2C (MEF2C))

Andere Bezeichnung: MEF2C (MEF2C Produkte)

Synonyme: MEF2C antikoerper, XMEF2C antikoerper, si:ch211-202e12.2 antikoerper, C5DELq14.3 antikoerper, DEL5q14.3 antikoerper, 5430401D19Rik antikoerper, 9930028G15Rik antikoerper, AV011172 antikoerper, Mef2 antikoerper, RGD1563119 antikoerper, id:ibd5026 antikoerper, mef2c antikoerper, wu:fc05b06 antikoerper, zgc:64184 antikoerper, zgc:85726 antikoerper, myocyte enhancer factor 2C antikoerper, MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C) antikoerper, myocyte enhancer factor 2cb antikoerper, MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C) L homeolog antikoerper, myocyte enhancer factor 2ca antikoerper, MEF2C antikoerper, mef2c antikoerper, mef2cb antikoerper, mef2c.L antikoerper, Mef2c antikoerper, mef2ca antikoerper

Gen-ID: 4208

Pathways: Neurotrophin Signalübertragung, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Chromatin Binding, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development, Toll-Like Receptors Cascades, BCR Signaling